Biotech News

Candel Therapeutics Appoints Maria Ostrovsky as General Counsel

Candel Therapeutics (CADL)Candel TherapeuticsPartnership

Seasoned legal and compliance executive brings global product launch, strategic transaction and international operational experience as Candel prepares for its planned Biologics License Application (BLA) submission and potential commercialization NEEDHAM, Mass., Oct.

Related news

Candel Therapeutics

Multimodal Cancer Immunotherapy Candel Therapeutics develops locally administered viral immunotherapies intended to induce immunogenic tumor-cell death and a systemic antitumor immune response. Aglatimagene Besadenovec Aglatimagene is an off-the-shelf, replication-defective adenovirus that delivers the HSV-thymidine-kinase gene into...

Recent company news

Stock data

Close
5.13 USD
Market cap
616.94M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States